Form 4 for ICUI ICU MEDICAL INC/DE
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001410442-23-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-08 | 2023-03-06+ | ICUI | Jain Vivek | COB, CEO, Dir | M - OptEx | $0.00 | +17.5K | 17.2K | New | $0 |
| DM | 2023-03-08 | 2023-03-06+ | ICUI | Jain Vivek | COB, CEO, Dir | F - Tax | $159.82 | -9,217 | 16.3K | -36% | -$1.47M |
| DM | 2023-03-08 | 2023-03-06+ | ICUI | Jain Vivek | COB, CEO, Dir | M - OptEx | $0.00 | -17.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-08 | M | A | 2,525 | $0.00 | 25,091 | D | — | — | (F1) These securities are Restricted Stock Units. |
| 2 | Common | Common Stock | 2023-03-08 | F | D | 1,329 | $156.17 | 23,762 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-07 | F | D | 1,694 | $157.47 | 22,566 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-07 | M | A | 3,218 | $0.00 | 24,260 | D | — | — | (F1) These securities are Restricted Stock Units. |
| 5 | Common | Common Stock | 2023-03-06 | F | D | 5,261 | $161.25 | 21,042 | D | — | — | |
| 6 | Common | Common Stock | 2023-03-06 | M | A | 9,994 | $0.00 | 26,303 | D | — | — | |
| 7 | Common | Common Stock | 2023-03-06 | F | D | 933 | $161.25 | 16,309 | D | — | — | |
| 8 | Common | Common Stock | 2023-03-06 | M | A | 1,773 | $0.00 | 17,242 | D | — | — | (F1) These securities are Restricted Stock Units. |
| 9 | Derivative | Common Stock | 2023-03-08 | M | D | 2,525 | $0.00 | 2,525 | D | $0.00 · 2022-03-08 to 2024-03-08 | 2,525 Common Stock | (F1) These securities are Restricted Stock Units. (F3) There is neither a purchase price nor an exercise price for the Restricted Stock Units. (F4) One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. (F5) These are restricted stock units that fully vest 3 years from the grant date. |
| 10 | Derivative | Performance Shares | 2023-03-06 | M | D | 9,994 | $0.00 | 0 | D | — · 2023-03-06 to 2023-03-06 | 9,994 Common Stock | (F6) These Securities are Performance-based Restricted Stock Units (PRSU). (F7) There is neither a purchase price nor an exercise price for the PRSUs. (F8) These PRSUs were granted on March 6, 2020 and were subject to the satisfaction of both performance-based and time-based criteria. These PRSUs had a 3-year performance period and cliff-vested on the third anniversary of the grant date. |
| 11 | Derivative | Common Stock | 2023-03-07 | M | D | 3,218 | $0.00 | 6,436 | D | $0.00 · 2023-03-07 to 2025-03-07 | 3,218 Common Stock | (F1) These securities are Restricted Stock Units. (F3) There is neither a purchase price nor an exercise price for the Restricted Stock Units. (F4) One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. (F5) These are restricted stock units that fully vest 3 years from the grant date. |
| 12 | Derivative | Common Stock | 2023-03-06 | M | D | 1,773 | $0.00 | 0 | D | $0.00 · 2022-03-06 to 2023-03-06 | 1,773 Common Stock | (F1) These securities are Restricted Stock Units. (F3) There is neither a purchase price nor an exercise price for the Restricted Stock Units. (F4) One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. (F5) These are restricted stock units that fully vest 3 years from the grant date. |